Demircan, N. C. Et Al. 2023. Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.19, no.1 , 104-112.

Demircan, N. C., Atci, M. M., Demir, M., Isik, S., & Akagunduz, B., (2023). Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.19, no.1, 104-112.

Demircan, Nazim Et Al. "Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy," ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.19, no.1, 104-112, 2023

Demircan, Nazim C. Et Al. "Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy." ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.19, no.1, pp.104-112, 2023

Demircan, N. C. Et Al. (2023) . "Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy." ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , vol.19, no.1, pp.104-112.

@article{article, author={Nazim Can Demircan Et Al. }, title={Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy}, journal={ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY}, year=2023, pages={104-112} }